ClinicalTrials.gg
RecruitingNCT07262801Updated Dec 4, 2025

Psychological and Physiological Impact of a Mindfulness-based Intervention on Anxiety Disorders During the Postpartum Period

An interventional study of 4-week mindfulness-based intervention in Postpartum Anxiety and Anxiety Disorders, sponsored by St. Joseph's Healthcare Hamilton. Recruiting at 2 sites in Canada. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-04.

Sponsored by St. Joseph's Healthcare Hamilton · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 384 studies in Anxiety Disorders with a site in Canada — 83 open to participants now, 91 under way, 1 of them phase 3. Anxiety Disorders · Canada.

Planned enrollment
235th of 350
50 · median 80
Started
2025
with 29 others
No phase
277 of 384
70 open now
Primary completion
2026-09
later than 39 of 90 live
Registered
367th of 384
by date

Among the 384 studies in Anxiety Disorders with a site in Canada, this one is the 235th largest by planned enrollment of the 350 interventional ones that give a count, is one of 30 that started in 2025, is one of 277 with no phase, reaches primary completion later than 39 of the 90 other live ones, and was the 367th registered.

Anxiety Disorders

7,249 studies on the registry are indexed under Anxiety Disorders; 1,691 are open to participants now.

Browse Anxiety Disorders studies →

Open to participants now

83 of the 384 studies in Anxiety Disorders with a site in Canada are open now. Recruiting first, the newest first:

77 more — sign in →

All 83 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 947 Anxiety Disorders studies recruiting now, 423 (45%) set no upper age limit and 455 (48%) stop at 75 or younger; 233 take children under 18; 319 take healthy volunteers.

This study: 18 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 384 studies in Anxiety Disorders with a site in Canada, or all of them as a file.
02

Study summary

Postpartum anxiety (PPA) affects up to 20% of mothers in the first year after delivery, with mothers often reporting both psychological and physical symptoms. Present non-pharmacological interventions are effective at improving some psychological aspects of PPA such as anxiety, depressive mood, and distress. However, current interventions are not effective in improving emotion regulation (ER), something that many with PPA experience impairment in. Current interventions also seldom target the physical aspects of anxiety, such as bodily awareness - sensing and understanding internal signals in the body (e.g., sensing a fast heartbeat). There is a link between ER and bodily awareness, however psychological interventions that target both these aspects have not been investigated in the PPA population. As a result, a mind-body intervention targeting both ER and bodily awareness is needed to offer a more holistic treatment option.

The purpose of the proposed study is to test the effectiveness of a 4-week mindfulness intervention on anxiety symptoms, ER, and bodily awareness in those with PPA. We will use self-report questionnaires alongside brain imaging (functional magnetic resonance imaging; fMRI) to evaluate the effectiveness. Combining both subjective and objective measures will provide greater confidence in our findings, ensuring a more comprehensive understanding of the intervention's impact. Self-report questionnaires will be administered at enrolment, immediately post-intervention, and 4 weeks post-intervention. Brain imaging will be conducted at enrolment and immediately post-intervention. We believe this intervention will lead to improvements in anxiety symptoms, ER, and bodily awareness on the questionnaires and fMRI scans.

If effective, the proposed mindfulness intervention will target a broader range of psychological and physical symptoms, and reduce the negative impact of PPA on mothers and their infants in Canada and beyond.

03

Conditions studied

  • Postpartum Anxiety
  • Anxiety Disorders

Keywords

  • postpartum anxiety
  • anxiety disorders
  • mothers
  • mindfulness
  • mindfulness-based intervention
  • emotion regulation
  • interoception
  • fMRI
  • resting state functional connectivity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • mothers/birthing parents 18 years and older who are between 0-12 months postpartum
  • principal diagnosis of an anxiety disorder as per the Diagnostic Assessment Research Tool (DART; Schneider et al., 2022), with or without comorbid depression
  • no concurrent psychological treatment
  • not taking psychoactive medication or a) medications are stable in dose and type for at least 8 weeks prior to the study (as per Canadian psychiatric guidelines; McQueen et al., 2016) and b) medications remain stable throughout the study
  • fluent in English, minimal grade 8 reading level.

Exclusion criteria

Exclusion Criteria:

  • severe depression/suicidality requiring acute intervention
  • women with psychotic or current alcohol or substance use disorders
  • suffering from severe claustrophobia
  • metallic objects in body (metal implants, pacemakers)
  • currently pregnant
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    4-week mindfulness intervention

    Behavioral: 4-week mindfulness-based intervention

  • No intervention
    Waitlist treatment as usual control

Interventions

  • Behavioral4-week mindfulness-based intervention

    This is the first mindfulness-based intervention specifically designed for postpartum mothers and birthing parents with clinical anxiety. The protocol is adapted from Mindfulness-Based Cognitive Therapy for Depression (by J. Mark G. Williams, John D. Teasdale, and Zindel Segal), and is explicitly tailored to address anxiety disorders during the postpartum period. Most existing mindfulness-based protocols primarily target anxiety during pregnancy, are suitable for both clinical and subclinical levels of anxiety, and are commonly applied to both postpartum depression and anxiety populations.

06

What researchers measure

Primary outcomes

  1. State-Trait Inventory for Cognitive and Somatic Anxiety (STICSA)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

Secondary outcomes

  1. Difficulties in Emotion Regulation Scale (DERS)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  2. Penn State Worry Questionnaire (PSWQ)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  3. Generalized Anxiety Disorder 7-Item Scale (GAD-7)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  4. Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  5. World Health Organization Quality of Life Scale (WHOQoL)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  6. Perceived Stress Scale (PSS)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  7. Multidimensional Assessment of Interoceptive Awareness 2 (MAIA-2)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  8. Interoceptive Sensitivity and Attention Questionnaire (ISAQ)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  9. Five Facet Mindfulness Questionnaire Short Form (FFMQ-SF)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  10. Postpartum Bonding Questionnaire (PBQ)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  11. Social Provisions Scale (SPS)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

  12. The Dyadic Adjustment Scale (DAS)

    Time frame: Administered at baseline (at enrolment), post-intervention (immediately after the 4 week intervention), and at the 3 months follow-up (3 months after intervention completion).

Other outcomes

  1. Resting State Functional Connectivity (fMRI)

    Time frame: Completed at baseline (at enrolment) and post-intervention (immediately after the 4 week intervention), in participants randomized to the experimental group only.

07

Study locations

2 of 2 sites recruiting
  • Women's Health Concerns Clinic, St. Joseph's Healthcare Hamilton
    Hamilton, Ontario, Canada
    Recruiting
  • Women's Health Concerns, St. Joseph's Healthcare Hamilton
    Hamilton, Ontario, Canada
    Recruiting
08

References and documents

Publications

  • Babiy Z, Frey BN, McCabe RE, Bieling PJ, Minuzzi L, Puccinelli C, Green SM. Mindfulness-Based Intervention for Treatment of Anxiety Disorders During the Postpartum Period: A 4-Week Proof-of-Concept Randomized Controlled Trial Protocol. Brain Sci. 2026 Jan 13;16(1):88. doi: 10.3390/brainsci16010088. PubMed 41594809 ↗

Individual participant data

Plan to share: Yes — Experimental group participants will be given the option to consent to having their de-identified REDCap questionnaires and fMRI scans data shared with the Canadian Biomarker Integration Network in Depression (CAN-BIND). CAN-BIND is a standardized research platform that supports large-scale collaboration by collecting and curating data from both healthy and clinical populations. If one chooses to provide this optional consent, their data may be used to support future ethically approved research projects. All shared data will be encrypted and de-identified to protect privacy as CAN-BIND follows strict ethical and data security standards, comparable to those at St. Joseph's Healthcare Hamilton.

Supporting information: Informed consent form

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2025; primary completion for Sep 2026, 9 months later.

Of 3,871 non-industry interventional studies with no phase under Anxiety Disorders, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 9 months is below that.

Counting every sponsor, half of 3,976 studies reached it within 12 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 19, 2025
First posted
Dec 4, 2025
StartEst.
Dec 2025
Primary completionEst.
Sep 2026
CompletionEst.
Sep 2026
Last update
Dec 4, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07262801
Responsible party
Sheryl Green (Dr. Sheryl Green, Ph.D., C.Psych, St. Joseph's Healthcare Hamilton) — Principal investigator
First posted
Dec 4, 2025
Start date
Dec 2025 (estimated)
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Dec 4, 2025

Study contacts

Sheryl M Green, Ph.D., C.Psych
Contact
sgreen@stjosham.on.ca
905-522-1155 ext. 33672
Zoryana Babiy, M.Sc.
Contact
babiyz@mcmaster.ca
Sheryl M Green, Ph.D., C.Psych
principal investigator · St. Joseph's Healthcare Hamilton
Benicio N Frey, MD, PhD, FRCPC
study chair · St. Joseph's Healthcare Hamilton
Zoryana Babiy, M.Sc.
study director · McMaster University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion